JP2017504576A5 - - Google Patents

Download PDF

Info

Publication number
JP2017504576A5
JP2017504576A5 JP2016536162A JP2016536162A JP2017504576A5 JP 2017504576 A5 JP2017504576 A5 JP 2017504576A5 JP 2016536162 A JP2016536162 A JP 2016536162A JP 2016536162 A JP2016536162 A JP 2016536162A JP 2017504576 A5 JP2017504576 A5 JP 2017504576A5
Authority
JP
Japan
Prior art keywords
phenyl
acetamide
hydroxypropan
hexafluoro
cyclopropylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016536162A
Other languages
English (en)
Japanese (ja)
Other versions
JP6461960B2 (ja
JP2017504576A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/076390 external-priority patent/WO2015082533A1/en
Publication of JP2017504576A publication Critical patent/JP2017504576A/ja
Publication of JP2017504576A5 publication Critical patent/JP2017504576A5/ja
Application granted granted Critical
Publication of JP6461960B2 publication Critical patent/JP6461960B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016536162A 2013-12-05 2014-12-03 RORガンマ(γ)モジュレータ Expired - Fee Related JP6461960B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13195813 2013-12-05
EP13195813.4 2013-12-05
EP14183274.1 2014-09-02
EP14183274 2014-09-02
PCT/EP2014/076390 WO2015082533A1 (en) 2013-12-05 2014-12-03 Ror gamma (rory) modulators

Publications (3)

Publication Number Publication Date
JP2017504576A JP2017504576A (ja) 2017-02-09
JP2017504576A5 true JP2017504576A5 (2) 2018-12-27
JP6461960B2 JP6461960B2 (ja) 2019-01-30

Family

ID=52021176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016536162A Expired - Fee Related JP6461960B2 (ja) 2013-12-05 2014-12-03 RORガンマ(γ)モジュレータ

Country Status (29)

Country Link
US (1) US9738600B2 (2)
EP (1) EP3077372B8 (2)
JP (1) JP6461960B2 (2)
KR (1) KR102251128B1 (2)
CN (1) CN105980353B (2)
AU (1) AU2014359324B2 (2)
CA (1) CA2932483C (2)
CL (1) CL2016001364A1 (2)
CR (1) CR20160303A (2)
DK (1) DK3077372T3 (2)
DO (1) DOP2016000125A (2)
EA (1) EA030393B1 (2)
ES (1) ES2722409T3 (2)
HR (1) HRP20190483T1 (2)
HU (1) HUE043258T2 (2)
IL (1) IL246018B (2)
LT (1) LT3077372T (2)
MX (1) MX368721B (2)
MY (1) MY179106A (2)
PE (1) PE20160891A1 (2)
PH (1) PH12016501066A1 (2)
PL (1) PL3077372T3 (2)
PT (1) PT3077372T (2)
RS (1) RS58650B1 (2)
SI (1) SI3077372T1 (2)
TN (1) TN2016000224A1 (2)
UA (1) UA117941C2 (2)
WO (1) WO2015082533A1 (2)
ZA (1) ZA201604043B (2)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015145371A1 (en) * 2014-03-27 2015-10-01 Piramal Enterprises Limited Ror-gamma modulators and uses thereof
US9718817B2 (en) * 2014-04-16 2017-08-01 Glenmark Pharmaceuticals S.A. Aryl and heteroaryl ether compounds as ROR gamma modulators
EP3212641B1 (en) 2014-10-30 2018-12-05 Janssen Pharmaceutica NV Thiazoles as modulators of roryt
TWI667230B (zh) 2014-10-30 2019-08-01 比利時商健生藥品公司 用作RORγt調節劑之三氟甲基醇
WO2016069978A1 (en) 2014-10-30 2016-05-06 Janssen Pharmaceutica Nv AMIDE SUBSTITUTED THIAZOLES AS MODULATORS OF RORγT
WO2016145298A1 (en) 2015-03-12 2016-09-15 The Regents Of The University Of California METHODS FOR TREATING CANCER WITH RORgamma INHIBITORS
SMT202100286T1 (it) 2015-05-15 2021-07-12 Aurigene Discovery Tech Ltd Composti di tetraidrochinolinone sostituito come modulatori ror-gamma
WO2016193894A1 (en) * 2015-05-29 2016-12-08 Glenmark Pharmaceuticals S.A. Treatment of respiratory disorders using ror- gamma inhibitors
EP3101008A1 (en) * 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
EP3101005A1 (en) * 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
WO2017010399A1 (ja) * 2015-07-10 2017-01-19 塩野義製薬株式会社 RORγt阻害作用を有する化合物およびそれらを含有する医薬組成物
CN109071516B (zh) 2015-12-15 2021-08-31 阿斯利康(瑞典)有限公司 新颖的化合物
TW201803869A (zh) 2016-04-27 2018-02-01 健生藥品公司 作為RORγT調節劑之6-胺基吡啶-3-基噻唑
AR109042A1 (es) * 2016-07-14 2018-10-24 Cadila Healthcare Ltd COMPUESTOS MODULARES DE RORg
TW201811760A (zh) 2016-07-14 2018-04-01 印度商卡迪拉保健有限公司 新穎的環丙基衍生物
AR110481A1 (es) * 2016-12-05 2019-04-03 Lead Pharma Holding Bv MODULADORES DE ROR g (RORg)
WO2018116285A1 (en) * 2016-12-23 2018-06-28 Glenmark Pharmaceuticals S.A. Substituted morpholine derivatives as ror gamma modulators
JP2020524660A (ja) 2017-06-14 2020-08-20 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag Ror−ガンマモジュレーターとして有用な2,3−ジヒドロイソインドール−1−カルボキサミド
ES2925473T3 (es) 2018-06-18 2022-10-18 Janssen Pharmaceutica Nv Pirazoles de piridinilo como moduladores de RORyt
JP2021528405A (ja) 2018-06-18 2021-10-21 ヤンセン ファーマシューティカ エヌ.ベー. RORγtのモジュレータとしてのアミド置換チアゾール
EP3806958B1 (en) 2018-06-18 2022-09-07 Janssen Pharmaceutica NV 6-aminopyridin-3-yl pyrazoles as modulators of roryt
CA3103770A1 (en) 2018-06-18 2019-12-26 Janssen Pharmaceutica Nv Phenyl and pyridinyl substituted imidazoles as modulators of roryt
TWI839461B (zh) 2019-02-06 2024-04-21 美商戴斯阿爾法股份有限公司 Il-17a調節物及其用途
IL291345B2 (en) 2019-09-16 2024-04-01 Dice Alpha Inc Il-17a modulators and uses thereof
CN112759541B (zh) * 2019-10-21 2023-03-17 复旦大学 类吲哚衍生物及其用途
TW202136238A (zh) * 2020-01-06 2021-10-01 大陸商廣東東陽光藥業有限公司 RORγt抑制劑及其製備方法和用途
CN113072521B (zh) * 2020-01-06 2024-04-05 广东东阳光药业股份有限公司 RORγt抑制剂及其在药物中的应用
CN114075139B (zh) * 2020-08-14 2025-09-26 广东东阳光药业股份有限公司 五元杂芳环类化合物及其在药物中的应用
CN120383557A (zh) * 2024-01-26 2025-07-29 上海医药集团股份有限公司 一种乙磺酰苯基乙酰胺类化合物的晶型、其制备方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115892A1 (en) * 2010-03-15 2011-09-22 Griffin Patrick R Modulators of the retinoic acid receptor-related orphan receptors
WO2012027965A1 (en) * 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
WO2013029338A1 (en) * 2011-09-01 2013-03-07 Glaxo Group Limited Novel compounds
ES2619610T3 (es) * 2012-10-16 2017-06-26 Janssen Pharmaceutica Nv Moduladores de ROR-gamma-t de quinolinilo enlazado con heteroarilo
WO2013171729A2 (en) 2013-01-08 2013-11-21 Glenmark Pharmaceuticals S.A. Aryl and heteroaryl amide compounds as rorgamat modulator
CN105121404A (zh) * 2013-03-15 2015-12-02 豪夫迈·罗氏有限公司 作为RORc调节剂的芳基磺酰胺和氨基磺酸衍生物
EP2781217A1 (en) * 2013-03-18 2014-09-24 ETH Zurich ROR gamma modulators

Similar Documents

Publication Publication Date Title
JP2017504576A5 (2)
RU2351590C2 (ru) Способ получения диариламина
TWI685491B (zh) 製備5-(4-環丙基-1h-咪唑-1-基)-n-(6-(4-異丙基-4h-1,2,4-三唑-3-基)吡啶-2-基)-2-氟-4-甲基苯甲醯胺之方法
AU2014359324B2 (en) ROR gamma (RORy) modulators
JP6511346B2 (ja) ハロゲン化環式化合物の合成方法
JP6854386B2 (ja) リゾホスファチジン酸受容体1(lpar1)阻害剤化合物
JP2016121196A5 (2)
JP7368365B2 (ja) P300/cbp hat阻害剤及びそれらの使用の方法
JP2016505058A5 (2)
JP2008510770A5 (2)
JP2016519165A5 (2)
JP2013521301A5 (2)
JP2019527724A5 (2)
JP2002515433A (ja) 抗ウイルス化合物
RU2014145481A (ru) Циклопропанкарбоксилатные эфиры пуриновых аналогов
JP2015507004A5 (2)
JP2007505879A (ja) 既知の抗高脂血症剤の多形体
WO2012174685A1 (zh) 一种2-取代-2h-1,2,3-三氮唑衍生物的制备方法
JP2013541589A5 (2)
ES2965478T3 (es) Protodescarboxilación catalizada por metales de transición de derivados del ácido alfa-halo-acrílico
JP2018510192A5 (2)
CN107531634A (zh) 作为wnt信号通路抑制剂的3‑氨基甲酰基苯基‑4‑甲酰胺和间苯二甲酰胺衍生物
CN115867542A (zh) 新型苯并咪唑化合物
CN105745193A (zh) 新型抗真菌氧代二氢吡啶碳酰肼衍生物
CN110483417A (zh) 一种DACOs类NNRTIs氨基酸酯衍生物、其制备方法、药物组合物及应用